1. Home
  2. ORKT vs UBX Comparison

ORKT vs UBX Comparison

Compare ORKT & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • UBX
  • Stock Information
  • Founded
  • ORKT 2003
  • UBX 2009
  • Country
  • ORKT Singapore
  • UBX United States
  • Employees
  • ORKT N/A
  • UBX N/A
  • Industry
  • ORKT
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • UBX Health Care
  • Exchange
  • ORKT NYSE
  • UBX Nasdaq
  • Market Cap
  • ORKT 34.7M
  • UBX 36.9M
  • IPO Year
  • ORKT 2024
  • UBX 2018
  • Fundamental
  • Price
  • ORKT $1.23
  • UBX $2.19
  • Analyst Decision
  • ORKT Strong Buy
  • UBX Strong Buy
  • Analyst Count
  • ORKT 1
  • UBX 2
  • Target Price
  • ORKT $5.00
  • UBX $7.00
  • AVG Volume (30 Days)
  • ORKT 6.9M
  • UBX 333.6K
  • Earning Date
  • ORKT 10-16-2024
  • UBX 11-04-2024
  • Dividend Yield
  • ORKT N/A
  • UBX N/A
  • EPS Growth
  • ORKT N/A
  • UBX N/A
  • EPS
  • ORKT N/A
  • UBX N/A
  • Revenue
  • ORKT $3,904,592.00
  • UBX N/A
  • Revenue This Year
  • ORKT N/A
  • UBX N/A
  • Revenue Next Year
  • ORKT N/A
  • UBX $33.62
  • P/E Ratio
  • ORKT N/A
  • UBX N/A
  • Revenue Growth
  • ORKT N/A
  • UBX N/A
  • 52 Week Low
  • ORKT $0.62
  • UBX $0.94
  • 52 Week High
  • ORKT $8.00
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • UBX 58.41
  • Support Level
  • ORKT N/A
  • UBX $1.81
  • Resistance Level
  • ORKT N/A
  • UBX $2.39
  • Average True Range (ATR)
  • ORKT 0.00
  • UBX 0.24
  • MACD
  • ORKT 0.00
  • UBX -0.05
  • Stochastic Oscillator
  • ORKT 0.00
  • UBX 59.38

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: